Barrow Hanley Mewhinney & Strauss LLC Merck & Co., Inc. Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $29.7 Billion
- Q3 2025
A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 7,415,270 shares of MRK stock, worth $689 Million. This represents 2.1% of its overall portfolio holdings.
Number of Shares
7,415,270
Previous 8,706,682
14.83%
Holding current value
$689 Million
Previous $689 Million
9.7%
% of portfolio
2.1%
Previous 2.44%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,877Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...